Urologic Health Completes $11M Seed Round

Urologic Health raised $11 million in seed funding to advance its non-invasive urodynamics platform.

The round was led by a strategic investor, with backing from several healthcare investors including Edge Medical Ventures, SHD Partners, Longevity Venture Partners, EdgeLabs, and MEDX Xelerator.

The company will use the capital for clinical validation, FDA 510(k) submission, and early U.S. commercialization.

Its catheter-free bladder assessment device aims to make urodynamic testing easier, more repeatable, and less invasive.